-
Entity
-
Individual
-
Location
-
C/O Retrophin, Inc., 12255 El Camino Real, Suite 250, San Diego, CA
-
Summary
-
The estimated net worth of Roy D. Baynes is at least $3.51M dollars as of February 12, 2025. Roy D. Baynes is the Director of Natera, Inc. and owns shares of Natera, Inc. (NTRA) stock worth about $2.81M. Roy D. Baynes is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $682K. Roy D. Baynes is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $16.9K.